Peter G Traber's Net Worth
$1.52 Million
Who is Peter G Traber?
Peter G Traber has an estimated net worth of $1.52 Million. This is based on reported shares across multiple companies, which include TANOX INC, SELECTA BIOSCIENCES INC, GALECTIN THERAPEUTICS INC, and Caladrius Biosciences, Inc..
SEC CIK
Peter G Traber's CIK is 0001284500
Past Insider Trading and Trends
2021 was Peter G Traber's most active year for acquiring shares with 12 total transactions. Peter G Traber's most active month to acquire stocks was the month of December. 2023 was Peter G Traber's most active year for disposing of shares, totalling 5 transactions. Peter G Traber's most active month to dispose stocks was the month of December. 2020 saw Peter G Traber paying a total of $189,421.76 for 708,292 shares, this is the most they've acquired in one year. In 2018 Peter G Traber cashed out on 340,000 shares for a total of $1,160,997.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TANOX INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SELECTA BIOSCIENCES INC (RNAC) Snapshot price: $0.6483
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.16% | -705.00 |
$1.06 | -$747.30 | 451.83K |
Sep 25
| |||
Form 4
| -2.54% | -11.64K |
$1.13 | -$13,185.32 | 446.12K |
Jan 4 - Jan 5
| |||
Form 4
| +77.59% | 200K |
—
|
—
| 457.76K |
Jan 2
| |||
Form 4
| -1.27% | -3.23K |
$3.09 | -$9,955.11 | 251.35K |
Jan 5
| |||
Form 4
| +54.87% | 90.2K |
—
|
—
| 254.58K |
Jan 3
| |||
Form 4
| -2.42% | -4.08K |
$2.99 | -$12,195.51 | 164.38K |
Dec 10
| |||
Form 4
| +8.89% | 13.75K |
—
|
—
| 168.46K |
Dec 8
| |||
Form 4
| -2.30% | -3.64K |
$4.39 | -$15,962.04 | 154.71K |
Oct 13
| |||
Form 4
| +9.51% | 13.75K |
—
|
—
| 158.35K |
Oct 1
| |||
Form 4
| +6.72% | 9.1K |
—
|
—
| 144.6K |
Sep 24
| |||
Form 4
| +17.32% | 20K |
$3.99 | $79,850.00 | 135.5K |
May 26
| |||
Form 4
| +17.86% | 17.5K |
$3.37 | $58,897.50 | 115.5K |
May 24 - May 25
| |||
Form 4
| +25.64% | 20K |
$4.51 | $90,295.00 | 98K |
Mar 17 - Mar 18
| |||
Form 4
| +95.00% | 38K |
—
|
—
| 78K |
Jan 4
| |||
Form 4
|
∞
| 40K |
$3.24 | $129,424.00 | 40K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GALECTIN THERAPEUTICS INC (GALT) Snapshot price: $1.62
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$4.19 | -$664,000.00 | 107.33K |
Scheduled
|
Jun 13
| ||
Form 4
|
—
|
0
|
$3.37 | -$349,097.00 | 107.33K |
Scheduled
|
Jun 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
| +1.90% | 2K |
$2.00 | $4,000.00 | 107.33K |
Aug 12
| |||
Form 4
| +3.95% | 4K |
$2.53 | $10,120.00 | 105.33K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
| +4.11% | 4K |
$4.46 | $17,837.80 | 101.33K |
Aug 14
| |||
Form 4
| +1.04% | 1K |
$4.42 | $4,415.50 | 97.33K |
Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
| +0.52% | 500 |
$8.90 | $4,450.00 | 96.33K |
Dec 9
| |||
Form 4
| +0.52% | 500 |
$9.00 | $4,500.00 | 95.83K |
Dec 5
| |||
Form 4
| +1.06% | 1K |
$5.53 | $5,530.00 | 95.33K |
Nov 19
| |||
Form 4
| +0.20% | 1K |
$5.80 | $5,799.20 | 511K |
Nov 18
| |||
Form 4
| +0.49% | 2.5K |
$2.11 | $5,287.00 | 510K |
Oct 12
| |||
Form 4
| +0.50% | 2.5K |
$2.00 | $5,000.00 | 507.5K |
Oct 9
| |||
Form 4
| +1.00% | 5K |
$2.07 | $10,350.00 | 505K |
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
∞
| 500K |
—
|
—
| 500K |
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Caladrius Biosciences, Inc. (LSTA) Snapshot price: $2.6481
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +78.12% | 65.43K |
—
|
—
| 149.19K |
Jan 10
| |||
Form 4
| +81.99% | 37.73K |
—
|
—
| 83.76K |
Jan 11
| |||
Form 4
| +65.96% | 18.29K |
$3.28 | $59,997.76 | 46.02K |
Jan 13
| |||
Form 4
| +77.64% | 12.12K |
$4.95 | $59,998.95 | 27.73K |
Jan 14
| |||
Form 4
| +127.41% | 8.75K |
—
|
—
| 15.61K |
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
| +59.65% | 2.56K |
—
|
—
| 6.87K |
May 16
| |||
Form 4
| +62.26% | 1.65K |
—
|
—
| 4.3K |
Jan 9
| |||
Form 4
| +39.47% | 7.5K |
—
|
—
| 26.5K |
Jun 22
| |||
Form 4
| +90.00% | 9K |
—
|
—
| 19K |
Jan 25
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||